EOM Pharmaceutical Holdings Inc. (IMUC)

[bob smith]

looking it as a pure trader, imuc just broke against the bullish trend looking at the next support at $2.52.
after stating that, this biotech has several catlysts that have been listed by several members during coming 4-6 weeks, suggesting that chart playing can be dangerous.

though profit is profit.

true question that needs to addressed is the cash value, and does it have the 4 million dollar equity to get listed for amex. (As i believe it has the cash).

The company has methodically orchestrated a story, and the stock continues to have strong postive sentiment on its side, for now.


Long on this one!

another footnote, below is a link from a person on the ICT trial.
feel good story.

http://glioblasted.wordpress.com/category/treatments/
2 excerpts:

1. The MRI from my March 19, 2012, Cycle 4 appointment at UAB revealed no tumor recurrence. The cavity in my brain looks good.

Tina breathed a big sigh of relief.

I was unfazed. I mean, I was glad to hear the good news, but was not surprised at all. We then drove three hours back to Atlanta.

Upon returning home, I was immediately overcome with fatigue, collapsed into bed and slept heavily for several hours. Now this was a surprise to me because I’ve been getting plenty of sleep, including the night before. I suspect that while I consciously don’t feel any sense of anxiety or fear about the cancer manifesting as a deadly tumor, I might unconsciously carry it as an exhausting burden. Maybe hearing the good news allowed me to release a tension of which I was not aware.

In any case, I feel great now.

2. The transfer from Chicago to Birmingham is complete. I’m officially participating in the ICT-107 clinical trial at the Kirklin Center at UAB as of January 23, 2012. This visit concludes Cycle 2 of the Extended Maintenance Phase. I had an MRI. The images showed no tumor growth. Things look pretty good. I will continue with chemo. My weight is down to 160 pounds. Dosage for Cycle 3 is 400mg of Temodar




gl